Qureight

Cambridge-based MedTech company Qureight has successfully closed an oversubscribed Series B funding round, securing £15 million ($20 million) in investment. The round was led by Molten Ventures and saw participation from existing investors including Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind, and Ascension.

Summary of transaction details:

• Value: £15 million ($20 million)
• Sector: Healthcare & Biotech
• Advisor: Not mentioned
• Key Entities: Qureight (Target), Molten Ventures (Lead Investor), Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind, Ascension (Participating Investors)
• Location: Cambridge, UK (Target company)

Note: This capital infusion will be instrumental in expanding Qureight's 3D deep-learning imaging portfolio, establishing a new AI imaging lab, and accelerating commercial growth into key new therapeutic markets for lung and heart diseases, further solidifying its leadership in the lung and heart imaging CRO market.